Literature DB >> 24008333

Delineation of the GPRC6A receptor signaling pathways using a mammalian cell line stably expressing the receptor.

Stine Engesgaard Jacobsen1, Lenea Nørskov-Lauritsen, Alex Rojas Bie Thomsen, Sanela Smajilovic, Petrine Wellendorph, Niklas H P Larsson, Anders Lehmann, Vikram Kjøller Bhatia, Hans Bräuner-Osborne.   

Abstract

The GPRC6A receptor is a recently "deorphanized" class C G protein-coupled receptor. We and others have shown that this receptor is coactivated by basic l-α-amino acids and divalent cations, whereas other groups have also suggested osteocalcin and testosterone to be agonists. Likewise, the GPRC6A receptor has been suggested to couple to multiple G protein classes albeit via indirect methods. Thus, the exact ligand preferences and signaling pathways are yet to be elucidated. In the present study, we generated a Chinese hamster ovary (CHO) cell line that stably expresses mouse GPRC6A. In an effort to establish fully the signaling properties of the receptor, we tested representatives of four previously reported GPRC6A agonist classes for activity in the Gq, Gs, Gi, and extracellular-signal regulated kinase signaling pathways. Our results confirm that GPRC6A is activated by basic l-α-amino acids and divalent cations, and for the first time, we conclusively show that these responses are mediated through the Gq pathway. We were not able to confirm previously published data demonstrating Gi- and Gs-mediated signaling; neither could we detect agonistic activity of testosterone and osteocalcin. Generation of the stable CHO cell line with robust receptor responsiveness and optimization of the highly sensitive homogeneous time resolved fluorescence technology allow fast assessment of Gq activation without previous manipulations like cotransfection of mutated G proteins. This cell-based assay system for GPRC6A is thus useful in high-throughput screening for novel pharmacological tool compounds, which are necessary to unravel the physiologic function of the receptor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24008333     DOI: 10.1124/jpet.113.206276

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  29 in total

1.  Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.

Authors:  Yuan Liao; Bin Lu; Qiang Ma; Gang Wu; Xiangru Lai; Jiashu Zang; Ying Shi; Dongxiang Liu; Feng Han; Naiming Zhou
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

Review 2.  Bone as an endocrine organ relevant to diabetes.

Authors:  Sarah L Booth; Amanda J Centi; Caren Gundberg
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

3.  The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway.

Authors:  Stine Engesgaard Jacobsen; Ina Ammendrup-Johnsen; Anna Mai Jansen; Ulrik Gether; Kenneth Lindegaard Madsen; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2017-03-09       Impact factor: 5.157

4.  BNGR-A25L and -A27 are two functional G protein-coupled receptors for CAPA periviscerokinin neuropeptides in the silkworm Bombyx mori.

Authors:  Zhangfei Shen; Yu Chen; Lingjuan Hong; Zhenteng Cui; Huipeng Yang; Xiaobai He; Ying Shi; Liangen Shi; Feng Han; Naiming Zhou
Journal:  J Biol Chem       Date:  2017-08-24       Impact factor: 5.157

5.  Genetic Variations in the Human G Protein-coupled Receptor Class C, Group 6, Member A (GPRC6A) Control Cell Surface Expression and Function.

Authors:  Stine Jørgensen; Christian Theil Have; Christina Rye Underwood; Lars Dan Johansen; Petrine Wellendorph; Anette Prior Gjesing; Christinna V Jørgensen; Shi Quan; Gao Rui; Asuka Inoue; Allan Linneberg; Niels Grarup; Wang Jun; Oluf Pedersen; Torben Hansen; Hans Bräuner-Osborne
Journal:  J Biol Chem       Date:  2016-12-16       Impact factor: 5.157

6.  The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo.

Authors:  M S Grace; T Lieu; B Darby; F C Abogadie; N Veldhuis; N W Bunnett; P McIntyre
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

7.  On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2016-03-05       Impact factor: 5.858

8.  β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.

Authors:  Douglas G Tilley; Weizhong Zhu; Valerie D Myers; Larry A Barr; Erhe Gao; Xue Li; Jianliang Song; Rhonda L Carter; Catherine A Makarewich; Daohai Yu; Constantine D Troupes; Laurel A Grisanti; Ryan C Coleman; Walter J Koch; Steven R Houser; Joseph Y Cheung; Arthur M Feldman
Journal:  Circulation       Date:  2014-09-09       Impact factor: 29.690

9.  Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues.

Authors:  Min Pi; Karan Kapoor; Yunpeng Wu; Ruisong Ye; Susan E Senogles; Satoru K Nishimoto; Dong-Jin Hwang; Duane D Miller; Ramesh Narayanan; Jeremy C Smith; Jerome Baudry; L Darryl Quarles
Journal:  Mol Endocrinol       Date:  2015-10-06

Review 10.  The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function.

Authors:  C Clemmensen; S Smajilovic; P Wellendorph; H Bräuner-Osborne
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.